2 July 2012 | Press Release | generic medicines, India, Treatment Access
ADVOCACY FOR FAIR ACCESS TO QUALTITY HEALTH CAREHEALTH PRODUCTS AND PHARMACEUTICAL SYSTEMFighting HIV / AIDS
After four years of secret negociations on the Anti-Counterfeiting Trade Agreement (ACTA) by the European Commission, the EU Parliament will finally be able to take position and vote on the agreement that threatens acces to medicine for milions of people living with HIV all over the world.
ACTA establishes a confusion between legitimate generics and counterfeit medicines and allows their seizure and destruction. It will jeopardize the arrival of cheap generic drugs and hinder the access to essential medicine that milions of sick people need to stay alive.
During the last four years, the civil society stood up against this argeement by increasing the number of demonstrations and petitions around Europe. Within the EU Parliament, the five consulted Committies (Civil Liberties, Industry, Legal Affairs, Development and International Trade) took stand against ACTA.
On the 4th of July, the eurodeputies will have to vote on the treaty in plenary session. They must draw consequences from the massive opposition to ACTA and definitively reject it as a whole.
Signataires :
Act Up-Paris
Act Up Sud-Ouest
Actions Traitements
AIDES
ALCOS Alliance Contre le SIDA
Coalition PLUS
Collectif Hépatites Virales
Ensemble pour une sante solidaire
GAPS
HF Égalité
HF Prévention
HomoFesty
Le patchwork des noms
Médecins du Monde – France
Sidaction
Solidarité Sida
Solthis
UNALS
